Home › NCT06414863
Effects of Invisalign Palatal Expander System
Recruiting
Treatment Effects of Invisalign Palatal Expander System and Hyrax Palatal Expander - A Randomized Controlled Trial
Who can join
Ages 6 to 14 · All sexes
Full eligibility criteria
Inclusion criteria: 1. Mixed dentition phase with at least three nonmobile (stable) teeth which have more than 1/4 of primary molar root length left16 in either side 2. Early permanent dentition stage and early permanent dentition but second permanent molars not yet fully erupted in the arch 3. Unilateral or bilateral posterior cross bite patients; or Patients who have been diagnosed with transverse maxillary deficiency (Skeletal transverse discrepancy measured from the estimated center of resistances of the first molars17 ≤ - 3 mm); 4. Patients with Class I or Class II skeletal relationship 5. Subjects willing to consent to the trial Exclusion Criteria: 1. Any general medical health problems which may influence treatment 2. Any craniofacial anomalies 3. Skeletal Class III patients 4. Mixed dentition patients with more than 2 heavily restored primary second or permanent first molars.
About the study
The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.
What is being tested
- IPE (device)
- HE (device)
Sponsor: University of the Pacific · Participants: 120 · Started: May 10, 2024
Contact the study team
- Heeyeon Suh · Phone: 415-351-7134
Official record on ClinicalTrials.gov — NCT06414863
Locations in the U.S.
| California | University of the Pacific, San Francisco |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.